CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Revenues: Clearing and transaction fees 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 1,227.9 Market data and information services 167.6 167.2 175.4 175.0 178.2 181.6 194.5 198.1 202.5 Other Revenue 84.7 87.6 103.6 107.6 109.1 111.4 110.5 105.9 107.2 Total revenues 1,337.8 1,439.3 1,487.9 1,532.5 1,584.4 1,525.3 1,642.3 1,692.0 1,537.6 Expenses: Compensation and benefits 205.5 212.9 206.0 204.7 218.8 220.8 206.7 221.6 237.6 Technology 55.6 58.5 59.4 64.1 66.6 65.7 65.7 70.9 71.4 Professional fees and outside services 32.2 36.1 33.1 34.7 31.0 33.9 28.5 37.4 36.7 Amortization of purchased intangibles 57.2 55.6 55.2 55.5 55.7 55.3 55.2 56.1 56.2 Depreciation and amortization 31.1 30.7 30.1 28.7 28.2 28.1 27.3 27.3 26.4 Licensing and other fee agreements 79.5 80.4 87.9 85.9 97.6 84.0 96.6 96.2 81.6 Other expense 56.5 101.9 56.6 58.3 62.3 90.4 54.3 53.2 55.1 Operating expenses 517.6 576.1 528.3 531.9 560.2 578.2 534.3 562.7 565.0 Operating Income 820.2 863.2 959.6 1,000.6 1,024.2 947.1 1,108.0 1,129.3 972.6 Operating Margin 61% 60% 64% 65% 65% 62% 67% 67% 63% Non-operating Income and Expense Investment income 1,272.5 1,076.9 1,071.3 1,044.5 1,026.8 936.5 892.7 1,518.4 1,548.7 Interest and other borrowing costs (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) (44.0) Equity in net gains (losses) of unconsolidated subsidiaries 76.8 66.8 87.2 86.4 86.1 91.2 88.2 99.0 96.3 Other non-operating income (expense) (1,155.6) (961.2) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) (1,396.6) Non-operating income (expense) 154.1 142.8 153.8 153.9 152.7 149.5 136.8 201.0 204.4 Income before income taxes 974.3 1,006.0 1,113.4 1,154.5 1,176.9 1,096.6 1,244.8 1,330.3 1,177.0 Income taxes 224.1 191.4 258.2 271.3 264.1 222.0 288.6 305.2 269.0 Net income 750.2 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 908.0 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 750.2 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 908.0 Net Income Attributable to Common Shareholders of CME Group 740.8 804.3 844.4 872.1 901.3 863.7 944.2 1,012.2 896.6 Effective Tax Rate 23.0% 19.0% 23.2% 23.5% 22.4% 20.2% 23.2% 22.9% 22.9% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.06 2.24 2.35 2.43 2.51 2.40 2.63 2.81 2.49 Diluted EPS 2.06 2.24 2.35 2.42 2.50 2.40 2.62 2.81 2.49 Weighted average number of common stock shares: Basic Shares 359,020 359,197 359,258 359,330 359,400 359,568 359,613 359,658 359,686 Diluted Shares 359,619 359,693 359,833 359,869 359,989 360,050 360,227 360,355 360,422 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Revenues: Clearing and transaction fees 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 1,227.9 Market data and information services 167.6 167.2 175.4 175.0 178.2 181.6 194.5 198.1 202.5 Other Revenue 84.7 87.6 103.6 106.6 109.2 111.3 110.5 105.9 107.2 Total revenues 1,337.8 1,439.3 1,487.9 1,531.5 1,584.5 1,525.2 1,642.3 1,692.0 1,537.6 Expenses: Compensation and benefits 193.5 204.4 196.1 201.7 207.5 218.9 207.8 212.5 225.0 Technology 55.6 58.5 59.4 64.1 66.6 65.7 65.7 70.9 71.3 Professional fees and outside services 32.2 36.1 33.1 34.7 31.0 33.9 25.2 27.0 27.0 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 31.1 29.8 29.3 28.7 28.2 28.0 27.3 26.9 26.4 Licensing and other fee agreements 79.5 80.4 87.9 85.9 97.6 84.0 96.6 96.2 81.6 Other expense 56.5 80.3 56.5 58.6 57.9 89.7 52.0 57.7 55.3 Operating expenses 448.4 489.5 462.3 473.7 488.8 520.2 474.6 491.2 486.6 Operating Income 889.4 949.8 1,025.6 1,057.8 1,095.7 1,005.0 1,167.7 1,200.8 1,051.0 Operating Margin 66% 66% 69% 69% 69% 66% 71% 71% 68% Non-operating Income and Expense Investment income 1,276.6 1,068.5 1,061.7 1,033.0 1,022.3 943.8 892.3 1,510.7 1,542.1 Interest and other borrowing costs (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) (44.0) Equity in net gains (losses) of unconsolidated subsidiaries 90.4 85.1 100.7 98.8 99.7 104.8 110.4 112.2 112.2 Other non-operating income (expense) (1,157.1) (958.8) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) (1,396.6) Non-operating income (expense) 170.3 155.1 157.7 154.8 161.8 170.4 158.6 206.5 213.7 Income before income taxes 1,059.7 1,104.9 1,183.3 1,212.6 1,257.5 1,175.4 1,326.3 1,407.3 1,264.7 Income taxes 241.7 240.2 272.2 280.4 280.5 256.5 306.4 327.9 286.3 Net income 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 978.4 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 978.4 Net Income Attributable to Common Shareholders of CME Group 807.8 853.8 899.7 920.4 964.7 907.4 1,007.1 1,065.8 966.1 Effective Tax Rate 22.8% 21.7% 23.0% 23.1% 22.3% 21.8% 23.1% 23.3% 22.6% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.25 2.38 2.50 2.56 2.68 2.52 2.80 2.96 2.69 Diluted EPS 2.25 2.37 2.50 2.56 2.68 2.52 2.80 2.96 2.68 Weighted average number of common stock shares: Basic Shares 359,020 359,197 359,258 359,330 359,400 359,568 359,613 359,658 359,686 Diluted Shares 359,619 359,693 359,833 359,869 359,989 360,050 360,227 360,355 360,422 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --